Compare SNBR & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SNBR | SWKH |
|---|---|---|
| Founded | 1987 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Diversified Financial Services |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 241.3M | 205.9M |
| IPO Year | 1998 | 1999 |
| Metric | SNBR | SWKH |
|---|---|---|
| Price | $9.09 | $17.25 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $10.00 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 601.9K | 6.3K |
| Earning Date | 03-04-2026 | 03-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 120.89 |
| EPS | N/A | ★ 1.85 |
| Revenue | ★ $1,440,882,000.00 | $40,149,000.00 |
| Revenue This Year | N/A | $52.93 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $9.18 |
| Revenue Growth | N/A | ★ 62.38 |
| 52 Week Low | $3.49 | $13.17 |
| 52 Week High | $18.67 | $20.49 |
| Indicator | SNBR | SWKH |
|---|---|---|
| Relative Strength Index (RSI) | 41.93 | 54.99 |
| Support Level | $11.05 | $16.75 |
| Resistance Level | $13.94 | $17.49 |
| Average True Range (ATR) | 1.12 | 0.21 |
| MACD | -0.36 | -0.03 |
| Stochastic Oscillator | 8.49 | 81.61 |
Sleep Number Corp. is a wellness technology company engaged in the design, manufacturing, marketing and distribution of sleep solutions. The Company generates revenue by marketing and selling its smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). The products offered by the company are Mattresses, Bedding, Pillows and Furniture.
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.